These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 16690926)

  • 21. Second-site long terminal repeat (LTR) revertants of replication-defective human immunodeficiency virus: effects of revertant TATA box motifs on virus infectivity, LTR-directed expression, in vitro RNA synthesis, and binding of basal transcription factors TFIID and TFIIA.
    Kashanchi F; Shibata R; Ross EK; Brady JN; Martin MA
    J Virol; 1994 May; 68(5):3298-307. PubMed ID: 8151790
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interactions of thyroid hormone receptor with the human immunodeficiency virus type 1 (HIV-1) long terminal repeat and the HIV-1 Tat transactivator.
    Desai-Yajnik V; Hadzic E; Modlinger P; Malhotra S; Gechlik G; Samuels HH
    J Virol; 1995 Aug; 69(8):5103-12. PubMed ID: 7609079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. p73 Interacts with human immunodeficiency virus type 1 Tat in astrocytic cells and prevents its acetylation on lysine 28.
    Amini S; Mameli G; Del Valle L; Skowronska A; Reiss K; Gelman BB; White MK; Khalili K; Sawaya BE
    Mol Cell Biol; 2005 Sep; 25(18):8126-38. PubMed ID: 16135803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional similarities between HIV-1 Tat and DNA sequence-specific transcriptional activators.
    Madore SJ; Cullen BR
    Virology; 1995 Feb; 206(2):1150-4. PubMed ID: 7856090
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of Sp1 transcription factor with HIV-1 Tat protein: looking for cellular partners.
    Loregian A; Bortolozzo K; Boso S; Caputo A; Palù G
    FEBS Lett; 2003 May; 543(1-3):61-5. PubMed ID: 12753906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The human immunodeficiency virus long terminal repeat includes a specialised initiator element which is required for Tat-responsive transcription.
    Rittner K; Churcher MJ; Gait MJ; Karn J
    J Mol Biol; 1995 May; 248(3):562-80. PubMed ID: 7752225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperation between herpes simplex virus type 1-encoded ICP0 and Tat to support transcription of human immunodeficiency virus type 1 long terminal repeat in vivo can occur in the absence of the TAR binding site.
    Schafer SL; Vlach J; Pitha PM
    J Virol; 1996 Oct; 70(10):6937-46. PubMed ID: 8794337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phosphorylation of HIV Tat by PKR increases interaction with TAR RNA and enhances transcription.
    Endo-Munoz L; Warby T; Harrich D; McMillan NA
    Virol J; 2005 Feb; 2():17. PubMed ID: 15737233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sp1-dependent activation of a synthetic promoter by human immunodeficiency virus type 1 Tat protein.
    Kamine J; Subramanian T; Chinnadurai G
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8510-4. PubMed ID: 1924310
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
    Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
    Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naturally occurring genotypes of the human immunodeficiency virus type 1 long terminal repeat display a wide range of basal and Tat-induced transcriptional activities.
    Michael NL; D'Arcy L; Ehrenberg PK; Redfield RR
    J Virol; 1994 May; 68(5):3163-74. PubMed ID: 7908701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 Tat protein can transactivate a heterologous TATAA element independent of viral promoter sequences and the trans-activation response element.
    Roebuck KA; Rabbi MF; Kagnoff MF
    AIDS; 1997 Feb; 11(2):139-46. PubMed ID: 9030359
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Different members of the Sp1 multigene family exert opposite transcriptional regulation of the long terminal repeat of HIV-1.
    Majello B; De Luca P; Hagen G; Suske G; Lania L
    Nucleic Acids Res; 1994 Nov; 22(23):4914-21. PubMed ID: 7800480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cell cycle-regulated transcription by the human immunodeficiency virus type 1 Tat transactivator.
    Kashanchi F; Agbottah ET; Pise-Masison CA; Mahieux R; Duvall J; Kumar A; Brady JN
    J Virol; 2000 Jan; 74(2):652-60. PubMed ID: 10623726
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the tat and nef gene products of human immunodeficiency virus type 1 (HIV-1) on transcription controlled by the HIV-1 long terminal repeat and on cell growth in macrophages.
    Murphy KM; Sweet MJ; Ross IL; Hume DA
    J Virol; 1993 Dec; 67(12):6956-64. PubMed ID: 8230418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
    McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
    Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased spacing between Sp1 and TATAA renders human immunodeficiency virus type 1 replication defective: implication for Tat function.
    Huang LM; Jeang KT
    J Virol; 1993 Dec; 67(12):6937-44. PubMed ID: 8230415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cooperative actions of HIV-1 Vpr and p53 modulate viral gene transcription.
    Sawaya BE; Khalili K; Mercer WE; Denisova L; Amini S
    J Biol Chem; 1998 Aug; 273(32):20052-7. PubMed ID: 9685344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of novel T cell factor 4 (TCF-4) binding sites on the HIV long terminal repeat which associate with TCF-4, β-catenin, and SMAR1 to repress HIV transcription.
    Henderson LJ; Narasipura SD; Adarichev V; Kashanchi F; Al-Harthi L
    J Virol; 2012 Sep; 86(17):9495-503. PubMed ID: 22674979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
    de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
    Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.